Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients
NCT00904371
·
clinicaltrials.gov ↗
COMPLETED
Status
211
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Cardiovascular Diseases
Sponsor
Boehringer Ingelheim